ISSN: 0957-5235

Journal Home

Journal Guideline

Blood Coagulation and Fibrinolysis Q3 Unclaimed

Lippincott Williams and Wilkins Ltd. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Blood Coagulation and Fibrinolysis is a journal indexed in SJR in Medicine (miscellaneous) and Hematology with an H index of 79. It has an SJR impact factor of 0,361 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,361.

Blood Coagulation and Fibrinolysis focuses its scope in these topics and keywords: factor, activity, coagulation, willebrand, deposition, blood, von, fibrinolysis, v, crispaan, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Hematology (Q3) Medicine (miscellaneous) (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,361

SJR Impact factor

79

H Index

100

Total Docs (Last Year)

298

Total Docs (3 years)

2735

Total Refs

343

Total Cites (3 years)

276

Citable Docs (3 years)

1.17

Cites/Doc (2 years)

27.35

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Swiss Medical Weekly Q3
Neurologia Q3
Canadian Journal of Experimental Psychology Q3
Journal of Physiology and Pharmacology Q3
Revista do Instituto de Medicina Tropical de Sao Paulo Q3

Compare this journals

Aims and Scope

Best articles by citations

Fractions of aqueous and methanolic extracts from tomato (Solanum lycopersicum L.) present platelet antiaggregant activity

An in vitro model for the detection of reduced platelet sensitivity to acetylsalicylic acid

Early onset of heparin-induced thrombocytopenia with thrombosis after open heart surgery

Effects of a plasma-derived C1 esterase inhibitor on hemostatic activation, clot formation, and thrombin generation

vCJD screening and its implications for transfusion - strategies for the future?

Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys

Shear stress and the role of high molecular weight von Willebrand factor multimers in thrombus formation

An SP1-binding site polymorphism in the COLIAI gene and osteoporosis in Egyptian patients with thalassemia major

Mild factor VII deficiency due to heterozygosis is not associated with a bleeding tendency

Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation

Anti-thrombomodulin antibodies and venous thrombosis

Fibrinolysis: an unfinished agenda

SHOW MORE ARTICLES

Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome

Homozygous factor V Leiden mutation in two siblings presenting with acute myocardial infarction: a rare cause of myocardial infarction in the young

Viral safety of solvent/detergent-treated blood products

Successful treatment of post-exertion acute myocardial infarction by primary angioplasty and stenting in a patient with antiphospholipid antibody syndrome

Management of bleeding in a multi-transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of cross-matched platelets

Prolonged seated immobility-associated venous coagulability in a factor V Leiden heterozygote: a case-comparative study

Congenital combined deficiency of coagulation factors

Antithrombic and anti-atherogenic effects of partially defatted flaxseed meal using a laser-induced thrombosis test in apolipoprotein E and low-density lipoprotein receptor deficient mice

Patients with cirrhosis show a relative increase in thrombin generation that is correlated with lower antithrombin levels

Maternal low-level somatic mosaicism of Cys155Tyr of F9 in severe hemophilia B

No effect of the prothrombin G20210A mutation on protein C activation in a large kindred with type I protein C deficiency

Effects of vitamin K antagonist phenprocoumon on activated partial thromboplastin time measurement of direct thrombin inhibitors